Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-22

Clinical Trial Update: A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase IV trial assessing safety, tolerability and efficacy of Tinefcon in plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tinefcon

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED